Third Medical Affairs Roundtable: Effective Thought Leader Management - KXNet.com - Bismarck/Minot/Williston/Dickinson-KXNEWS,ND

Third Medical Affairs Roundtable: Effective Thought Leader Management

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Best Practices, LLC

CHAPEL HILL, N.C., June 13, 2014 /PRNewswire/ -- Research and Benchmarking firm, Best Practices, LLC hosted its third Medical Affairs Roundtable on Thursday, June, 5th to discuss "Effective Thought Leader Management"

The virtual conference, took place between 11 a.m. and 12:30 p.m. (Eastern Daylight Time), examined:

  • Improving coordination across functions and regions
  • Increasing the value of thought leader interaction
  • Optimum contact frequency with thought leaders
  • Leveraging new technologies

Our roundtable provided Medical Affairs executives a chance to discuss how peer companies are employing CRM and communication technologies to coordinate thought leader interactions across various departments and business units. "We are using a database which allows us to plan the coming up interactions, understand who owns these interactions, and which thought leaders are tied to them globally across different affiliates and teams.  This database helps us to be more strategic in when and how to use a thought leader," says one of the executives who joined the roundtable.  

Best Practices' CEO Chris Bogan, VP of Research and Advisory Services Jonathan Tanz and Executive Director Cameron Tew facilitated the roundtable discussion that is based on a research conducted with 40 medical affairs leaders from 32 leading life sciences companies. The discussion brought together executives from the following leading organizations: Amgen, Astellas, Astra Zeneca, Baxter, Eli Lilly, Forest Labs, Genentech, Merck, Novartis, Pfizer, ProStrakan, Sanofi, Teva.

The 3rd roundtable concluded the 2013-2014 Medical Affairs Consortium. However, we will be preparing to kick off the next Medical Affairs Consortium in July.

For more information regarding the Medical Affairs Consortium studies, please review our Weekly Medical Affairs Consortium Research Release.

To learn more about Medical Affairs Consortium, click on the following link: http://www.best-in-class.com/medical-affairs-consortium

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General information or questions:
kxinfo@kxnet.com

News:
Bismarck:
Phone: 701-223-9197
News Fax: 701-223-1985

News:
Minot:
Phone: 701-852-2104
News Fax: 701-838-1050
All content © Copyright 2000 - 2014 WorldNow and KXNET. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.